The new production facility will create 400 permanent jobs, and 1,000 external employees will be hired while the plant is under construction.
Written by UNN with reference to Danmarks Radio and Bloomberg.
The omeprazole manufacturer Novo Nordisk A/S has allocated 8.5 billion kroner (1.2 billion dollars) for the construction of a new plant in Denmark. Earlier, the company received the green light to buy three large facilities abroad for $11.7 billion.
The Danish pharmaceutical giant will set up a 40,000-square-meter (430,000-square-foot) manufacturing facility and warehouse on the outskirts of Denmark's third-largest city, Odense, a brand new location for the drugmaker, Novo said in a statement on Monday.
Ukraine has received an innovative drug for HIV prevention05.06.24, 10:36
The new production facility is expected to create 400 permanent jobs, and 1,000 external workers will be hired during the plant's establishment.
We are proud to be building on our heritage in Denmark and look forward to starting this journey in Odense, an attractive city with a dynamic community and talented workforce